TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: CUI (Clinical Utility Index)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Virological failure after treatment resumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DASS-21 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Thromboembolic events (TEs)
Endpoint domain: Adverse events/effects
Primary endpoint: recognition time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: injection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: procedure pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post‐traumatic stress symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants losing 5% or greater weight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CD4(+) T cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: immune activation markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: multiple surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: biliary fistula
Endpoint domain: Adverse events/effects
Primary endpoint: delayed gastric emptying
Endpoint domain: Adverse events/effects
Primary endpoint: mental disability index < 70
Endpoint domain: Adverse events/effects
Primary endpoint: High grade surgical complications
Endpoint domain: Adverse events/effects
Primary endpoint: Kappa statistic for the diagnosis of SAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fasting plasma glucose change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-h post-meal plasma glucose change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percent days abstinent at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol problems at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: likelihood of meeting criteria for alcohol dependence at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: weight bearing facilitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness in the treatment of mild to moderate depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: global health score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: children's sunscreen reapplication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: use of wide-brimmed hats
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hats/clothing self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Consistent use of contraceptive methods
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress management skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Production of CNS Abeta
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Thyroid stimulating hormone increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in visual analog scale levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood eosinophils counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sputum eosinophils counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: sputum ECP levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: state benefits
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: knee extensor peak torque
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: endurance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: whole-body lean mass loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SMVL (Severe Vision Loss)
Endpoint domain: Mortality/survival
Primary endpoint: kinematic variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Motor-task performance scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Aneurysm enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: CEF25‐75
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Total comprehension scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Inadequate vitamin D status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma 25(OH)D concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: KSS function score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: family supportive behaviours
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: patients' knowledge of and attitudes toward diabetes
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QT prolongation during hypoglycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in skin texture and pigmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Physician-rated FES improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: daily living functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of TSH target value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 3-month progression-free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: Grades 3 to 5 toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Number of pads per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type-specific persistence of HPV infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: 30-day postoperative rate of major bleeding
Endpoint domain: Adverse events/effects
Primary endpoint: rate of arterial thromboembolism
Endpoint domain: Adverse events/effects
Primary endpoint: Achieved hemostasis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hollander Cosmesis Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sICAM levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progressive renal insufficiency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Postoperative satisfaction scores for overall bowel function
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: primary graft failure (GF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of bactobilia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: absence rate of late complications
Endpoint domain: Adverse events/effects
Primary endpoint: Disimpaction rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reimpaction rate
Endpoint domain: Adverse events/effects
Primary endpoint: Blood hormone concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Blood chemistry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for radiofrequency neurotomy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Development of influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Chewing frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: General appetite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early caloric vestibular deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first independent walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total and LDL cholesterol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: arrhythmia identified or excluded
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: symptom‐rhythm correlation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progression to AIDS/death avoided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HIV-related illness avoided
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical progress of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increased testing for chlamydia trachomatis
Endpoint domain: Adverse events/effects
Primary endpoint: knee joint pain reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle thickness increase
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-reported function improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: waist and hip circumference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BMD (Bone Mineral Density)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Reduction in skin bacterial colony counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Improvement in DAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: white cell count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: pancreas graft loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: myocardial (re-)infarction at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: Adherence to postoperative care instructions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: success rates of foreign body removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of perioperative adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Diaphragm adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Rate (HR) and Mean Arterial Blood Pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Flight performance decrement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PD20 increase at methacholine test
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical improvement in rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Clinical improvement in asthma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VAS score of peripheral nasal symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Compliance to walking prescription
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Remission of CIN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall perioperative complication rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: incidence of postoperative coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ethanol consumption per drinking day
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: biochemical disease-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Attempts to contact a resource
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Survival free of myocardial infarction
Endpoint domain: Mortality/survival
Primary endpoint: Survival free of combined events
Endpoint domain: Mortality/survival
Primary endpoint: Progression of carotid atherosclerosis as measured by CIMT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maintenance of health behavior change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of metastatic NSCLC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Cleansing of the whole small bowel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Cleansing of the distal small bowel
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Length of distal small bowel containing green luminal contents
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: HK-DQI Knowledge scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: DCS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: PDMS scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: target dose homogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tumor control probability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Free T4 index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Free T3 index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in symptoms of allergic rhinitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in airflow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: quality of mother-infant engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Absolute bioavailability of oral docetaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in copeptin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Change in urine osmolality
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Prognostic marker of mortality
Endpoint domain: Mortality/survival
Primary endpoint: STC-VM response to increasing heart rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NF-kappa B expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: G0/1 phase cell proportion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: cell proliferation index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Functional independence measurement gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ROE values after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diminishing eczema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Levels of biopterin and pterin (B + P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median area under the curve of pain against time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median summary pain scores on movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of reoperation at adjacent levels
Endpoint domain: Adverse events/effects
Primary endpoint: Overall motor improvement measured by UPDRS-III
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of blood loss of 400 mL or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Energy balance deficit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Milk fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: American Orthopaedic Foot and Ankle Society clinical scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak GH values after GHRH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: procedural time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of induced complete miscarriage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of fever/rigors
Endpoint domain: Adverse events/effects
Primary endpoint: Perception of decision to undergo medical management as a good decision
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: decline of cognitive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Successful insertion of nasogastric tube
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in sensory gating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: confidence for change
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: binge eating symptomatology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axis deviation of the SIA axis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal HOAs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-bleeding within 5 days
Endpoint domain: Adverse events/effects
Primary endpoint: Release of salivary substance P‐IS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Release of salivary CGRP‐IS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Release of plasma CGRP‐IS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parasuicidal behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PCR-adjusted treatment failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Re-infections during follow up
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of pulmonary auscultation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Palliation of tumour-related symptoms
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Morphine equivalents consumed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean pain ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intrathecal minimum local analgesic dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative analgesic potency ratios
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patency rate of large middle meatal antrostomy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Optokinetic nystagmus (OKN) gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Saccade velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: performance on a reaction and line bisection task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effectiveness of sorafenib therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum resistin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of esophageal cancer
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of gastric cardia cancer
Endpoint domain: Mortality/survival
Primary endpoint: serum UA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Combined hyperglycaemia and arginine-stimulated C-peptide secretion (AIR(arg))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Ross heart failure score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean heart rates in Holter ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Odds of passing out
Endpoint domain: Adverse events/effects
Primary endpoint: Odds of not remembering the drinking event
Endpoint domain: Adverse events/effects
Primary endpoint: Odds of breaking/damaging property
Endpoint domain: Adverse events/effects
Primary endpoint: Odds of getting in a fight
Endpoint domain: Adverse events/effects
Primary endpoint: Embryo transplantation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Early abortion rate
Endpoint domain: Adverse events/effects
Primary endpoint: Family satisfaction with the program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing